These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7712387)

  • 1. [The pharmacokinetics of ceftazidime in the burned patients].
    Zong G; Xiao G; Zhang Y
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1994 Sep; 10(5):385-8. PubMed ID: 7712387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.
    Walstad RA; Aanderud L; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(5):543-9. PubMed ID: 3069478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
    Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.
    Conil JM; Georges B; Ravat F; Ruiz S; Seguin T; Metsu D; Fourcade O; Saivin S
    Clin Ther; 2013 Oct; 35(10):1603-12. PubMed ID: 24094465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of ceftazidime in burn patients.
    Dailly E; Pannier M; Jolliet P; Bourin M
    Br J Clin Pharmacol; 2003 Dec; 56(6):629-34. PubMed ID: 14616422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation.
    Conil JM; Georges B; Lavit M; Laguerre J; Samii K; Houin G; Saivin S
    Br J Clin Pharmacol; 2007 Jul; 64(1):27-35. PubMed ID: 17324245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics differences of propofol during different pathological stages of severe burn in rabbits].
    Hu QG; Hao JH; Chai JK; Yang HM; Sun XF; Li P; Li MM; Liu S
    Zhonghua Shao Shang Za Zhi; 2010 Feb; 26(1):37-40. PubMed ID: 20510032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
    Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fluid compartment changes during burn shock in the guinea pig.
    Ferguson JL; Hikawyj-Yevich I; Miller HI
    Circ Shock; 1980; 7(4):457-66. PubMed ID: 7226436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration.
    Conil JM; Georges B; Fourcade O; Seguin T; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Mar; 45(3):133-42. PubMed ID: 17416108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock.
    Oda J; Kasai K; Noborio M; Aoki Y; Yamashita K; Inoue T; Ueyama M; Yukioka T
    J Trauma; 2009 May; 66(5):1281-5. PubMed ID: 19430227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical investigation of the correlation between blood concentration of lactic acid and tissue oxygenation in severely burned patients].
    Su QH; Yu JJ; Yang MJ; Zhou HM; Zhu JQ
    Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):152-4. PubMed ID: 12921618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the pharmacokinetics of Imipenem cilastatin in burn patients during the acute phase].
    Wang H; Peng Y; Xiao G
    Zhonghua Shao Shang Za Zhi; 2000 Dec; 16(6):349-51. PubMed ID: 11876899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.
    Wise ER; Armstrong GC; Brown RM; Andrews JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():277-82. PubMed ID: 19802998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfer of latamoxef into human burn blister fluid and its pharmacokinetic analysis].
    Aoyama H; Sugiyama H; Suzuki I; Nishizaki A; Izawa Y; Oguma T; Yamada H
    Jpn J Antibiot; 1985 Oct; 38(10):2821-6. PubMed ID: 4078995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.
    Walstad RA; Dahl K; Hellum KB; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(3):273-9. PubMed ID: 3053209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
    Wittmann DH; Schassan HH; Kohler F; Seibert W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.